pubmed-article:11742901 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:11742901 | lifeskim:mentions | umls-concept:C0024109 | lld:lifeskim |
pubmed-article:11742901 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:11742901 | lifeskim:mentions | umls-concept:C0032105 | lld:lifeskim |
pubmed-article:11742901 | lifeskim:mentions | umls-concept:C0007202 | lld:lifeskim |
pubmed-article:11742901 | lifeskim:mentions | umls-concept:C0006100 | lld:lifeskim |
pubmed-article:11742901 | lifeskim:mentions | umls-concept:C0442805 | lld:lifeskim |
pubmed-article:11742901 | lifeskim:mentions | umls-concept:C2828389 | lld:lifeskim |
pubmed-article:11742901 | pubmed:issue | 6 | lld:pubmed |
pubmed-article:11742901 | pubmed:dateCreated | 2001-12-14 | lld:pubmed |
pubmed-article:11742901 | pubmed:abstractText | Hemodynamic complications including hypotensive episodes are frequently associated with cardiopulmonary bypass (CPB) and can be attributed to a generalized inflammatory response in which bradykinin may be a mediator. The purpose of this study was to determine the plasma levels of bradykinin-(1-9)nonapeptide in patients during CPB and the physiologic elimination of bradykinin by the lungs. | lld:pubmed |
pubmed-article:11742901 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11742901 | pubmed:language | eng | lld:pubmed |
pubmed-article:11742901 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11742901 | pubmed:citationSubset | AIM | lld:pubmed |
pubmed-article:11742901 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11742901 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11742901 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11742901 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:11742901 | pubmed:month | Dec | lld:pubmed |
pubmed-article:11742901 | pubmed:issn | 0012-3692 | lld:pubmed |
pubmed-article:11742901 | pubmed:author | pubmed-author:NussbergerJJ | lld:pubmed |
pubmed-article:11742901 | pubmed:author | pubmed-author:AgostoniAA | lld:pubmed |
pubmed-article:11742901 | pubmed:author | pubmed-author:CoppolaRR | lld:pubmed |
pubmed-article:11742901 | pubmed:author | pubmed-author:BiglioliPP | lld:pubmed |
pubmed-article:11742901 | pubmed:author | pubmed-author:AlamanniFF | lld:pubmed |
pubmed-article:11742901 | pubmed:author | pubmed-author:CugnoMM | lld:pubmed |
pubmed-article:11742901 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:11742901 | pubmed:volume | 120 | lld:pubmed |
pubmed-article:11742901 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:11742901 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:11742901 | pubmed:pagination | 1776-82 | lld:pubmed |
pubmed-article:11742901 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:11742901 | pubmed:meshHeading | pubmed-meshheading:11742901... | lld:pubmed |
pubmed-article:11742901 | pubmed:meshHeading | pubmed-meshheading:11742901... | lld:pubmed |
pubmed-article:11742901 | pubmed:meshHeading | pubmed-meshheading:11742901... | lld:pubmed |
pubmed-article:11742901 | pubmed:meshHeading | pubmed-meshheading:11742901... | lld:pubmed |
pubmed-article:11742901 | pubmed:meshHeading | pubmed-meshheading:11742901... | lld:pubmed |
pubmed-article:11742901 | pubmed:meshHeading | pubmed-meshheading:11742901... | lld:pubmed |
pubmed-article:11742901 | pubmed:meshHeading | pubmed-meshheading:11742901... | lld:pubmed |
pubmed-article:11742901 | pubmed:meshHeading | pubmed-meshheading:11742901... | lld:pubmed |
pubmed-article:11742901 | pubmed:meshHeading | pubmed-meshheading:11742901... | lld:pubmed |
pubmed-article:11742901 | pubmed:meshHeading | pubmed-meshheading:11742901... | lld:pubmed |
pubmed-article:11742901 | pubmed:meshHeading | pubmed-meshheading:11742901... | lld:pubmed |
pubmed-article:11742901 | pubmed:meshHeading | pubmed-meshheading:11742901... | lld:pubmed |
pubmed-article:11742901 | pubmed:meshHeading | pubmed-meshheading:11742901... | lld:pubmed |
pubmed-article:11742901 | pubmed:meshHeading | pubmed-meshheading:11742901... | lld:pubmed |
pubmed-article:11742901 | pubmed:meshHeading | pubmed-meshheading:11742901... | lld:pubmed |
pubmed-article:11742901 | pubmed:meshHeading | pubmed-meshheading:11742901... | lld:pubmed |
pubmed-article:11742901 | pubmed:meshHeading | pubmed-meshheading:11742901... | lld:pubmed |
pubmed-article:11742901 | pubmed:meshHeading | pubmed-meshheading:11742901... | lld:pubmed |
pubmed-article:11742901 | pubmed:year | 2001 | lld:pubmed |
pubmed-article:11742901 | pubmed:articleTitle | Increase of bradykinin in plasma of patients undergoing cardiopulmonary bypass: the importance of lung exclusion. | lld:pubmed |
pubmed-article:11742901 | pubmed:affiliation | Department of Internal Medicine, IRCCS Maggiore Hospital, University of Milan, Italy. | lld:pubmed |
pubmed-article:11742901 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:11742901 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11742901 | lld:pubmed |